Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer.

about

Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.

P2860

Q47656682-D85848F7-EAFE-4F34-A0A2-B6A7F8208E42

P2860

Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer.

Item

http://www.wikidata.org/entity/Q41443074

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of Symptom Score an ...... o Chemotherapy in Lung Cancer.

@en

type

Item

label

Comparison of Symptom Score an ...... o Chemotherapy in Lung Cancer.

@en

prefLabel

Comparison of Symptom Score an ...... o Chemotherapy in Lung Cancer.

@en

P1476

Comparison of Symptom Score an ...... o Chemotherapy in Lung Cancer.

@en

P2093

Ashutosh Nath Aggarwal

http://www.w3.org/2001/XMLSchema#string

Digambar Behera

http://www.w3.org/2001/XMLSchema#string

Lakshimikant Baburao Yenge

http://www.w3.org/2001/XMLSchema#string

Mandeep Garg

http://www.w3.org/2001/XMLSchema#string

Navneet Singh

http://www.w3.org/2001/XMLSchema#string

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Reporting results of cancer treatment

Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.

Simplified Graded Baseline Symptom Assessment in Patients With Lung Cancer Undergoing First-Line Chemotherapy: Correlations and Prognostic Role in a Resource-Constrained Setting

Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature.

Indications for performing flexible bronchoscopy: Trends over 34 years at a tertiary care hospital.

Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature.

Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classifica

P304

370-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JGO.2016.006593

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28831445

http://www.w3.org/2001/XMLSchema#string

P932

5560460

http://www.w3.org/2001/XMLSchema#string

Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer.

about

P2860

P2860

Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932